Chen Hu (physician)
Chen Hu (Chinese: 陈虎; 17 February 1962 – 24 July 2019) was a Chinese military physician and stem cell researcher. He served as Director of the PLA Institute of Hematopoietic Stem Cell Research and the Beijing Hematopoietic Stem Cell Therapy Laboratory. Known for his research on hematopoietic stem cell therapy for leukemia, he was awarded the State Science and Technology Progress Award (First Class) in 2015 and the Ho Leung Ho Lee Prize in 2016. In 2017, he and Deng Hongkui engineered resistance to HIV in mice using CRISPR gene editing, and for the first time used the technique on an AIDS patient. He died of a sudden heart attack before their findings were published.
Link from a Wikipage to another Wikipage
primaryTopic
Chen Hu (physician)
Chen Hu (Chinese: 陈虎; 17 February 1962 – 24 July 2019) was a Chinese military physician and stem cell researcher. He served as Director of the PLA Institute of Hematopoietic Stem Cell Research and the Beijing Hematopoietic Stem Cell Therapy Laboratory. Known for his research on hematopoietic stem cell therapy for leukemia, he was awarded the State Science and Technology Progress Award (First Class) in 2015 and the Ho Leung Ho Lee Prize in 2016. In 2017, he and Deng Hongkui engineered resistance to HIV in mice using CRISPR gene editing, and for the first time used the technique on an AIDS patient. He died of a sudden heart attack before their findings were published.
has abstract
Chen Hu (Chinese: 陈虎; 17 Febru ...... their findings were published.
@en
Wikipage page ID
61,853,921
page length (characters) of wiki page
Wikipage revision ID
988,544,389
Link from a Wikipage to another Wikipage
wikiPageUsesTemplate
subject
type
comment
Chen Hu (Chinese: 陈虎; 17 Febru ...... their findings were published.
@en
label
Chen Hu (physician)
@en